Transcription factor activating protein 4 is synthetically lethal and a master regulator of MYCN-amplified neuroblastoma

Despite the identification of MYCN amplification as an adverse prognostic marker in neuroblastoma, MYCN inhibitors have yet to be developed. Here, by integrating evidence from a whole-genome shRNA library screen and the computational inference of master regulator proteins, we identify transcription...

Descripción completa

Detalles Bibliográficos
Autores principales: Boboila, Shuobo, Lopez, Gonzalo, Yu, Jiyang, Banerjee, Debarshi, Kadenhe-Chiweshe, Angela, Connolly, Eileen P., Kandel, Jessica J., Rajbhandari, Presha, Silva, Jose M., Califano, Andrea, Yamashiro, Darrell J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6172192/
https://www.ncbi.nlm.nih.gov/pubmed/29880876
http://dx.doi.org/10.1038/s41388-018-0326-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6172192/
https://www.ncbi.nlm.nih.gov/pubmed/29880876
http://dx.doi.org/10.1038/s41388-018-0326-9

Ejemplares similares